# US 2024/0389905 A1 · System and method for mass spectrometry imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0389905 A1
- Document ID: US20240389905A1
- Status: Published application
- Kind: A1
- Application number: 18/789,390
- Filed: 2024-07-30
- Published: 2024-11-28
- Earliest claimed: 2018-06-05
- Assignees: Trace Matters Scientific LLC
- Applicants: Trace Matters Scientific LLC
- Inventors: Mazdak Taghioskoui
- Web page: https://patentgrep.com/patent/US20240389905A1

## CPC

- H01J 49/062: {Ion guides (linear ion traps performing mass selection H01J49/4225, mass filters H01J49/421)}
- H01J 49/065: {having stacked electrodes, e.g. ring stack, plate stack}
- A61B 5/0077: {Devices for viewing the surface of the body, e.g. camera, magnifying lens}
- A61B 5/444: {Evaluating skin marks, e.g. mole, nevi, tumour, scar}
- A61B 5/4842: {Monitoring progression or stage of a disease}
- A61B 5/6851: {Guide wires}
- A61B 5/6887: {mounted on external non-worn devices, e.g. non-medical devices}
- A61B 10/04: Endoscopic instruments, e.g. catheter-type instruments
- A61B 18/203: {applying laser energy to the outside of the body}
- A61B 18/22: the beam being directed along or through a flexible conduit, e.g. an optical fibre; {Couplings or} hand-pieces therefor
- G01N 33/4833: {of solid biological material, e.g. tissue samples, cell cultures (tissue in vivo A61B5/00; cell suspensions G01N33/48735)}
- H01J 49/0404: {Capillaries used for transferring samples or ions (electrospray nozzles H01J49/167)}
- H01J 49/068: {Mounting, supporting, spacing, or insulating electrodes}
- A61B 18/24: with a catheter (A61B18/26, A61B18/28 take precedence)
- A61B 18/26: for producing a shock wave, e.g. laser lithotripsy
- A61B 2018/00327: {Ear, nose or throat}
- A61B 2018/00476: {Hair follicles}
- A61B 2018/00488: {Esophagus}
- A61B 2018/00494: {Stomach, intestines or bowel}
- A61B 2018/00505: {Urinary tract}
- A61B 2018/00559: {Female reproductive organs}
- A61B 2018/00577: {Ablation}
- A61B 2018/00982: {combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes}
- A61B 2018/2035: {Beam shaping or redirecting; Optical components therefor (A61B2018/2255 takes precedence)}
- A61B 2018/2211: {Plurality of fibres}
- G01N 27/622: Ion mobility spectrometry
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method of analysis using mass spectrometry or ion mobility spectrometry that includes producing ions from a sample in a proximity of the sample, transferring the produced ions from the sample to a distance with a flexible or re-configurable ion guide, the flexible or re-configurable ion guide being connected to RF voltages, and separating the produced ions with a mass to charge or mobility analyzer located at the distance to provide spectrometric results; and detecting the separated ions with at least one detector.

## Claims

### Claim 1

A method for analyzing a sample using mass spectrometry or ion mobility spectrometry, the method comprising:
producing gas-phase ions and neutrals from the sample in a proximity of the sample;
transferring the produced ions from the sample to a distance via a flexible or re-configurable ion transfer device, the flexible or re-configurable ion transfer device employing RF voltages to transfer the ions;
separating the produced ions with a mass spectrometer or a mobility analyzer located at the distance to provide spectrometric results; and
detecting the separated ions with at least one detector.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the sample is a biological sample of a human subject or a non-human animal subject, or a specimen derived from said human or non-human animal subject.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the biological sample is in vivo tissue.

### Claim 4 (depends on 2)

The method according to claim 2, further comprising:
determining presence, type, grade, stage, or a combination thereof of a disease in one of more regions of the sample that is a biological sample based on the spectrometric results.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the determining is performed based on determining one or more biomarkers for the disease in the biological sample.

### Claim 6 (depends on 4)

The method according to claim 4, wherein the disease is one or more cancers, cancer tumors, or tumor margins.

### Claim 7 (depends on 1)

The method according to claim 1, further comprising:
separating the produced ions based on ion mobility in the flexible or re-configurable ion transfer device while transferring the produced ions along the ion transfer device.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the proximity is between 0.1 mm to 50 mm.

### Claim 9 (depends on 1)

The method according to claim 1, further comprising:
before transferring, ionizing the gas-phase neutrals in the proximity of the sample with one or more ionization sources.

### Claim 10 (depends on 9)

The method according to claim 9, wherein from the produced gas-phase ions and neutrals from the sample, only the produced ions from the sample is transferred by the ion transfer device.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the produced neutrals from the sample that are not ionized by the one or more ionization sources in the proximity of the sample, are not transferred in the transferring and are not separated in the separating.

### Claim 12 (depends on 11)

The method according to claim 11, wherein neutrals include one or more of aerosols, vapor, particles, or clusters from the sample.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the producing comprises:
performing ablation or desorption of the sample to produce a plume including the gas-phase ions and neutrals; and
ionizing the plume in the proximity of the sample with one or more ionization sources.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the performing ablation or desorption and the ionizing the plume are performed by irradiating laser pulses and electrospray ionization respectively.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the performing ablation or desorption and the ionizing the plume are performed by irradiating IR and UV laser pulses respectively.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the ionizing the plume is performed between 1 nanosecond to 5 seconds after the performing ablation or desorption.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the ionizing the plume is performed at ambient pressure or reduced pressure by one or more ambient pressure or reduced pressure ionization sources.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the one or more ambient pressure or reduced pressure ionization sources are UV lamp, UV laser, electrospray, gas discharge, or plasma, or combination of UV lamp, UV laser, electrospray, gas discharge, and plasma.

### Claim 19 (depends on 1)

The method according to claim 1, wherein length of the ion guide is greater than 10 cm, 50 cm, 100 cm, 150 cm, or 200 cm, 2 meters, 5 meters, or 10 meters.

### Claim 20 (depends on 1)

The method according to claim 1, wherein the producing ions from the sample in the proximity of the sample is performed by a hand-held probe.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the producing is performed by steering one or more laser beams on a surface of the sample to produce a chemical or biological spectrometric image of the surface with the spectrometric results.

### Claim 22 (depends on 2)

The method according to claim 2, wherein the producing ions from the biological sample in the proximity of the biological sample is performed by an endoscopic probe.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the producing is performed at one end of the endoscopic probe that inserted inside body and is in the proximity of the biological sample.

### Claim 24

An endoscopic ion source used with a mass spectrometer or an ion mobility analyzer for in vivo tissue analysis, the ion source comprising:
a multi-lumen tubing having a tip and a plurality of channels, the multi-lumen tubing configured to be inserted into human or animal body for the tip to reach a proximity of tissue;
one or more optical fibers positioned inside the plurality of channels, the one or more optical fibers configured to guide one or more laser beams from one or more laser sources to the tissue, the laser beams configured to produce gas-phase ions and neutrals by ablation, desorption, ionization, or a combination thereof from the tissue;
a first set of tubes positioned inside the plurality of channels configured to provide gas flow at the tip; and
a second set of tubes positioned inside the plurality of channels configured to suck in the produced gas-phase ions and neutrals from the tip of one of the second set of tubes, the one of the second set of tubes being connected to a voltage or ground.

### Claim 25 (depends on 24)

The endoscopic ion source according to claim 24, wherein the first set of tubes and the second set of tubes are concentric.

### Claim 26 (depends on 24)

The endoscopic ion source according to claim 24, wherein the first set of tubes and the second set of tubes are made of non-conductive materials or conductive materials, or a combination thereof.

### Claim 27 (depends on 24)

The endoscopic ion source according to claim 24, wherein the first set of tubes and the second set of tubes are concentric and provide a sampling inlet with curtain gas.

### Claim 28 (depends on 24)

The endoscopic ion source according to claim 24, wherein a first laser beam of the laser beams produces a plume including gas-phase ions and neutrals, and the second laser beam of the laser beams ionizes the plume in the proximity of the tissue.

### Claim 29 (depends on 28)

The endoscopic ion source according to claim 28, wherein the first laser beam and the second laser beam are respectively IR and UV laser pulses.

### Claim 30 (depends on 24)

The endoscopic ion source according to claim 24, further comprising:
one or more second ion sources configured to ionize a plume produced by one or more laser beams in the proximity of the tissue.

### Claim 31 (depends on 30)

The endoscopic ion source according to claim 30, wherein the one or more second ion sources ionize the plume by one or more ambient pressure or reduced pressure ionization sources.

### Claim 32 (depends on 31)

The endoscopic ion source according to claim 31, wherein the one or more second ion source ionizes the plume between 1 nanosecond to 5 seconds after the plume is produced.

### Claim 33 (depends on 31)

The endoscopic ion source according to claim 31, wherein the one or more ambient pressure or reduced pressure ionization sources are UV lamp, UV light emitting diode, UV laser, electrospray, gas discharge, or plasma, or a combination of UV lamp, UV light emitting diode, UV laser, electrospray, gas discharge, and plasma.

### Claim 34 (depends on 24)

The endoscopic ion source according to claim 24, wherein the proximity is between 0.1 mm to 50 mm.

### Claim 35 (depends on 24)

The endoscopic ion source according to claim 24, wherein a diameter of the multi-lumen tubing is less than 10 mm.

### Claim 36 (depends on 24)

The endoscopic ion source according to claim 24, wherein the first set of tubes, the second set of tubes, and the one or more optical fibers are bundled together and fixed in the multi-lumen tubing in a non-removable manner.

### Claim 37 (depends on 24)

The endoscopic ion source according to claim 24, wherein the first set of tubes, the second set of tubes, and the one or more optical fibers are positioned in the multi-lumen tubing in a removable manner.

### Claim 38 (depends on 24)

The endoscopic ion source according to claim 24, wherein a plurality of wheels control a position of the tip for navigation inside the body.

### Claim 39 (depends on 24)

The endoscopic ion source according to claim 24, wherein the produced ions and neutrals are sucked into at least one of the second set of tubes from one end at the tip and from other end enter a flexible or re-configurable ion transfer device to be transferred to a mass spectrometer or ion mobility analyzer, the flexible or re-configurable ion transfer device employing RF voltages to efficiently transfer the produced ions.

### Claim 40 (depends on 24)

The endoscopic ion source according to claim 24, wherein the ion source is connected to a flexible or re-configurable ion transfer device employing RF voltages to transfer the produced ions.

### Claim 41 (depends on 40)

The endoscopic ion source according to claim 40, wherein from the produced gas-phase ions and neutrals from the tissue, only the produced ions from the tissue are transferred by the ion transfer device.

### Claim 42 (depends on 40)

The endoscopic ion source according to claim 40, wherein the produced neutrals are not transferred by the ion transfer device if the produced neutrals are not ionized by the one or more ionization sources in the proximity of the tissue.

### Claim 43 (depends on 42)

The endoscopic ion source according to claim 42, wherein the produced neutrals include one or more of aerosols, vapor, particles, or clusters from the tissue.

### Claim 44 (depends on 24)

The endoscopic ion source according to claim 24, wherein the produced ions are analyzed with the mass spectrometer or the ion mobility analyzer located at the distance to produce spectrometric results.

### Claim 45 (depends on 44)

The endoscopic ion source according to claim 44, wherein presence, type, grade, stage, or combination thereof of a disease in one of more regions of the tissue is determined based on the spectrometric results.

### Claim 46 (depends on 45)

The endoscopic ion source according to claim 45, wherein the presence, type, grade, stage, or combination thereof of the disease is determined by determining one or more biomarkers for the disease in the tissue.

### Claim 47 (depends on 40)

The endoscopic ion source according to claim 40, wherein the ion transfer device is configured to be bent from one or more bend positions to form a plurality of curvatures.

### Claim 48 (depends on 47)

The endoscopic ion source according to claim 47, wherein the ion transfer device is configured to be bent from one or more bend positions to form a plurality of curvatures while actively and efficiently transferring the ions.

### Claim 49 (depends on 40)

The endoscopic ion source according to claim 40, wherein the ion transfer device comprises a plurality of electrodes configured to be flexibly connected to each other to make the ion transfer device re-configurable while actively transferring the ions to the mass spectrometer or the ion mobility analyzer.

### Claim 50 (depends on 40)

The endoscopic ion source according to claim 40, wherein
the ion transfer device is configured to be transformable between two or more different physical shapes, and
the ion transfer device is configured to transfer the ions in the two or more different physical shapes from the ion source to the mass spectrometer or the ion mobility analyzer.

### Claim 51 (depends on 40)

The endoscopic ion source according to claim 40, wherein the ion transfer device is maintained at a pressure between 0.0001 to 750 Torr.

### Claim 52 (depends on 40)

The endoscopic ion source according to claim 40, wherein the ion transfer device is re-configurable or transformable between at least a first configuration and a second configuration.

### Claim 53 (depends on 24)

The endoscopic ion source according to claim 24, wherein the endoscopic ion source is flexible.

### Claim 54 (depends on 24)

The endoscopic ion source according to claim 24, wherein the tip includes a protective cover.

### Claim 55 (depends on 24)

The endoscopic ion source according to claim 24, wherein pressure at one end of the second set of tubes that is in the proximity of the sample is atmospheric pressure of 760 Torr, and pressure at the other end of the second set of tubes is reduced pressure in range of 0.001 to 750 Torr.

### Claim 56 (depends on 24)

The endoscopic ion source according to claim 24, wherein at least one of the first set of tubes, the second set of tubes, and one or more optical fibers extend from the tip of the multi-lumen tubing.

### Claim 57

An ion source probe that produces ions from a sample for analysis by a mass spectrometer or ion mobility analyzer, the ion source probe comprising:
a housing;
one or more ion sources located inside the housing and configured to produce gas-phase ions and neutrals from the sample by ablation, desorption, ionization, or combination thereof in a proximity of the sample; and
an ion extractor located inside the housing and configured to extract and transfer the produced gas-phase ions and neutrals to a flexible or re-configurable ion transfer device connected to the probe, the flexible or re-configurable ion transfer device employing RF voltages to transfer the produced ions.

### Claim 58 (depends on 57)

The ion source probe according to claim 57, wherein the ion extractor includes a first set of tubes configured to suck in the produced gas-phase ions and neutrals from an inlet of one of the plurality of tubes.

### Claim 59 (depends on 58)

The ion source probe according to claim 58, wherein the ion extractor further includes a second set of tubes configured to provide gas flow.

### Claim 60 (depends on 59)

The ion source probe according to claim 59, wherein the first set of tubes and the second set of tubes are concentric.

### Claim 61 (depends on 58)

The ion source probe according to claim 58, wherein the first set of tubes and the second set of tubes are made of non-conductive materials or conductive materials, or a combination thereof, the conductive materials being connected to a voltage or ground.

### Claim 62 (depends on 58)

The ion source probe according to claim 58, wherein the first set of tubes and the second set of tube are concentric and provide a sampling inlet with curtain gas.

### Claim 63 (depends on 57)

The ion source probe according to claim 57, wherein the ion extractor includes a stacked ring ion guide, or an ion funnel.

### Claim 64 (depends on 57)

The ion source probe according to claim 57, wherein at least one of the one or more ion sources is a first laser beam that produces a plume including gas-phase ions and neutrals.

### Claim 65 (depends on 64)

The ion source probe according to claim 64, wherein at least another of the one or more ion sources is a second laser beam that ionizes the plume in the proximity of the sample.

### Claim 66 (depends on 65)

The ion source probe according to claim 65, wherein the ablation or desorption to create the plume and the ionization of the plume are respectively performed by irradiating IR and UV laser.

### Claim 67 (depends on 64)

The ion source probe according to claim 64, further comprising:
one or more second ion sources configured to ionize the plume in the proximity of the sample.

### Claim 68 (depends on 67)

The ion source probe according to claim 67, wherein the one or more second ion sources ionizes the plume by one or more ambient pressure or reduced pressure ionization sources.

### Claim 69 (depends on 68)

The ion source probe according to claim 68, wherein the one or more second ion source ionizes the plume between 1 nanosecond to 5 seconds after the plume is produced.

### Claim 70 (depends on 68)

The ion source probe according to claim 68, wherein the one or more ambient pressure or reduced pressure ionization sources are UV lamp, UV laser, electrospray, gas discharge, or plasma, or a combination of UV lamp, UV laser, electrospray, gas discharge, or plasma.

### Claim 71 (depends on 64)

The ion source probe according to claim 64, wherein a laser beam steering device steers laser beam on a surface of the sample to produce chemical composition imaging of the surface.

### Claim 72 (depends on 57)

The ion source probe according to claim 57, wherein the proximity is between 0.1 mm to 50 mm.

### Claim 73 (depends on 57)

The ion source probe according to claim 57, wherein the produced ions and neutrals are extracted and transferred by the ion extractor to a flexible or re-configurable ion transfer device to be transferred to a mass spectrometer or ion mobility analyzer, the flexible or re-configurable ion transfer device employing RF voltages to efficiently transfer the produced ions.

### Claim 74 (depends on 57)

The ion source probe according to claim 57, wherein the ion source probe is connected to a flexible or re-configurable ion transfer device employing RF voltages to transfer the produced ions.

### Claim 75 (depends on 74)

The ion source probe according to claim 74, wherein from the produced gas-phase ions and neutrals from the tissue, only the produced ions from the tissue are transferred by the ion transfer device.

### Claim 76 (depends on 74)

The ion source probe according to claim 74, wherein the produced neutrals are not transferred if the produced neutrals are not ionized by the one or more ionization sources in the proximity of the sample.

### Claim 77 (depends on 57)

The ion source probe according to claim 57, wherein the ions are analyzed with the mass spectrometer or the ion mobility analyzer located at the distance to provide spectrometric results.

### Claim 78 (depends on 77)

The ion source probe according to claim 77, wherein the sample is a biological sample of a human subject or a non-human animal subject, or a specimen derived from said human or non-human animal subject.

### Claim 79 (depends on 78)

The ion source probe according to claim 78, wherein the biological sample is in vivo tissue.

### Claim 80 (depends on 79)

The ion source probe according to claim 79, wherein presence, type, grade, stage, or a combination thereof of a disease in one of more regions of the tissue is determined based on the spectrometric results.

### Claim 81 (depends on 74)

The ion source probe according to claim 74, wherein the ion transfer device is configured to be bent from one or more bend positions to form a plurality of curvatures.

### Claim 82 (depends on 81)

The ion source probe according to claim 81, wherein the ion transfer device is configured to be bent from one or more bend positions to form a plurality of curvatures while actively and efficiently transferring the ions.

### Claim 83 (depends on 74)

The ion source probe according to claim 74, wherein the ion transfer device comprises a plurality of electrodes configured to be flexibly connected to each other to make the ion transfer device re-configurable while actively transferring the ions to the mass spectrometer or the ion mobility analyzer.

### Claim 84 (depends on 74)

The ion source probe according to claim 74, wherein
the ion transfer device is configured to be transformable between two or more different physical shapes, and
the ion transfer device is configured to transfer the ions in the two or more different physical shapes from the ion source probe to the mass spectrometer or the ion mobility analyzer.

### Claim 85 (depends on 74)

The ion source probe according to claim 74, wherein the ion transfer device is maintained at a pressure between 0.0001 to 750 Torr.

### Claim 86 (depends on 74)

The ion source probe according to claim 74, wherein the ion transfer device is re-configurable or transformable between at least a first configuration and a second configuration.

### Claim 87 (depends on 57)

The ion source probe according to claim 57, wherein pressure inside the housing is atmospheric pressure of 760 Torr.

### Claim 88 (depends on 57)

The ion source probe according to claim 57, wherein pressure inside the housing is reduced pressure in range of 0.0001 to 750 Torr.

### Claim 89 (depends on 57)

The ion source probe according to claim 57, wherein the sample is a sample of interest in forensic toxicology, metabolomics, proteomics, pharma or biopharma, and clinical research, drug testing and discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, or protein identification.
